Related references
Note: Only part of the references are listed.Exogenous supplement of N-acetylneuraminic acid improves macrophage reverse cholesterol transport in apolipoprotein E-deficient mice
Pengbo Hou et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Fucoidan A2 from the Brown Seaweed Ascophyllum nodosum Lowers Lipid by Improving Reverse Cholesterol Transport in C57BL/6J Mice Fed a High-Fat Diet
Zixun Yang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
Diesel Exhaust Induces Mitochondrial Dysfunction, Hyperlipidemia, and Liver Steatosis
Fen Yin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Insights into the chemistry and therapeutic potential of furanones: A versatile pharmacophore
Asif Husain et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
SREBP-1 and LXRα pathways mediated Cu-induced hepatic lipid metabolism in zebrafish Danio rerio
Ya-Xiong Pan et al.
CHEMOSPHERE (2019)
Statin Toxicity Mechanistic Insights and Clinical Implications
Natalie C. Ward et al.
CIRCULATION RESEARCH (2019)
PCSK9 inhibition 2018: riding a new wave of coronary prevention
Natalie C. Ward et al.
CLINICAL SCIENCE (2019)
Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats
Yongliang Zhao et al.
ATHEROSCLEROSIS (2018)
PPAR Agonists and Metabolic Syndrome: An Established Role?
Margherita Botta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Liver X receptors in lipid signalling and membrane homeostasis
Bo Wang et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Spiro-Phthalides and Isocoumarins Isolated from the Marine-Sponge-Derived Fungus Setosphaeria sp SCSIO41009
Xiaoyan Pang et al.
JOURNAL OF NATURAL PRODUCTS (2018)
Statin-Associated Muscle Disease: Advances in Diagnosis and Management
Beth A. Taylor et al.
NEUROTHERAPEUTICS (2018)
Role of SREBPs in Liver Diseases: A Mini-review
Azam Moslehi et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2018)
Stilbenoids and cannabinoids from the leaves of Cannabis sativa f. sativa with potential reverse cholesterol transport activity
Tiantian Guo et al.
FOOD & FUNCTION (2018)
Synthesis and cardiovascular protective effects of quercetin 7-O-sialic acid
Hua Tian et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
Ni Li et al.
MOLECULAR PHARMACOLOGY (2017)
Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis
Yvonne Baumer et al.
NATURE COMMUNICATIONS (2017)
Exogenous supplement of N-acetylneuraminic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice
Shoudong Guo et al.
ATHEROSCLEROSIS (2016)
Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease
Kristine Griffett et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
HDL functionality in reverse cholesterol transport - Challenges in translating data emerging from mouse models to human disease
Miriam Lee-Rueckert et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Liver X Receptor Activation Promotes Polyunsaturated Fatty Acid Synthesis in Macrophages Relevance in the Context of Atherosclerosis
Alexis Varin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
A novel therapeutic effect of statins on nephrogenic diabetes insipidus
Leonilde Bonfrate et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Spiromastixones Inhibit Foam Cell Formation via Regulation of Cholesterol Efflux and Uptake in RAW264.7 Macrophages
Chongming Wu et al.
MARINE DRUGS (2015)
Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8
Maria Thomas et al.
FRONTIERS IN PHARMACOLOGY (2015)
Higher level of plasma bioactive molecule sphingosine 1-phosphate in women is associated with estrogen
Shoudong Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Lipid-lowering effects of farnesylquinone and related analogues from the marine-derived Streptomyces nitrosporeus
Dong Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Fenofibrate-associated nephrotoxicity: A review of current evidence
Rebecca L. Attridge et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2013)
MicroRNA-217 Promotes Ethanol-induced Fat Accumulation in Hepatocytes by Down-regulating SIRT1
Huquan Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Lars Berglund et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Analysis and Purification of Bioactive Natural Products: The AnaPurNa Study
Guido F. Pauli et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo
Noemi Rotllan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2011)
TGF-beta 1 Up-Regulates Expression of ABCA1, ABCG1 and SR-BI through Liver X Receptor a Signaling Pathway in THP-1 Macrophage-Derived Foam Cells
Yan-Wei Hu et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression
S. Pierno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Statins and fibrate target ClC-1-from side effects to CLC pharmacology
Anselm A. Zdebik
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-α
Xian-sheng Huang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report
Jianyong Wu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Fenofibrate Simultaneously Induces Hepatic Fatty Acid Oxidation, Synthesis, and Elongation in Mice
Maaike H. Oosterveer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-IMilano
Giovanni Cimmino et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Effects and mechanisms of PPARα activator fenofibrate on myocardial remodelling in hypertension
Chuan-Bao Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Regulation of Bile Acid and Cholesterol Metabolism by PPARs
Tiangang Li et al.
PPAR RESEARCH (2009)
25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway
Yongjie Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Activation of peroxisome proliferator-activated receptor-α in mice induces expression of the hepatic low-density lipoprotein receptor
Z. Huang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment
Gilles Lambert et al.
CLINICAL CHEMISTRY (2008)
Fibrate-Associated Adverse Effects Beyond Muscle and Liver Toxicity
M. Elisaf et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Effects of combined PPAR gamma and PPAR alpha agonist therapy on reverse cholesterol transport in the Zucker diabetic fatty rat
J. Tanabe et al.
DIABETES OBESITY & METABOLISM (2008)
Purity-Activity Relationships of Natural Products: The Case of Anti-TB Active Ursolic Acid
Birgit U. Jaki et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
Janice Mayne et al.
LIPIDS IN HEALTH AND DISEASE (2008)
LXR is crucial in lipid metabolism
SM Ulven et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients
N Roglans et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Peroxisome proliferator-activated receptor α (PPARα) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart
BN Finck et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
PPARs: transcriptional effectors of fatty acids and their derivatives
AK Hihi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Share Paper
